Sanofi (SNY) - 5i Research

Sanofi (SNY $48.43)
- $48.43 P/E (TTM): 18.55X Cap: $121.08B
- View SNY Profile
- View Questions on SNY

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Sanofi (SNY $48.43)
- $48.43 P/E (TTM): 18.55X Cap: $121.08B
- View SNY Profile
- View Questions on SNY

Q: sanofi trades in a range over the long term. these days it seems to be either breaking out or topping its range. do you see this company dipping to its low end of its range ($45 ish) going forward or is a new higher range being formed.

Read Answer Asked by steve on September 04, 2024

Sanofi (SNY $48.43)
- $48.43 P/E (TTM): 18.55X Cap: $121.08B
- View SNY Profile
- View Questions on SNY

Q: Based on your last comments on June 24th about Sanofi could you please help me understand what's behind the recent drop with the stock recently and is this a good time to buy. Is it now at a "bargain" price what are the financial ratios you like and don't like about this stock? How do you feel about their pipeline of drugs?

Your last comment was SNY: Sanofi is a bit different than the others, being a $130 billion pharma company. The valuation fundamentals look fine, growth expectations are mid-to-low single digits on the top line and it pays a decent dividend. For an 'anchor' type of position, we would not take much issue with a name like this.

Read Answer Asked by James on August 11, 2022

Quest Diagnostics Incorporated (DGX $177.72)
- $177.72 P/E (TTM): 21.04X Cap: $18.58B
- View DGX Profile
- View Questions on DGX
Hologic Inc. (HOLX $65.36)
- $65.36 P/E (TTM): 26.87X Cap: $14.19B
- View HOLX Profile
- View Questions on HOLX
Sanofi (SNY $48.43)
- $48.43 P/E (TTM): 18.55X Cap: $121.08B
- View SNY Profile
- View Questions on SNY
The Cooper Companies Inc. (COO $72.93)
- $72.93 P/E (TTM): 34.45X Cap: $14.50B
- View COO Profile
- View Questions on COO
Emergent BioSolutions Inc. (EBS $7.07)
- $7.07 Cap: $379M
- View EBS Profile
- View Questions on EBS
QuidelOrtho Corp Com (QDEL $25.98)
- $25.98 Cap: $1.71B
- View QDEL Profile
- View Questions on QDEL

Q: Would like to invest in the health sector, looking for growth over 1-2 years. Could you comment on the above stocks

Read Answer Asked by Howie on June 24, 2021